ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

Naltrexone and Propranolol Combined With Immunotherapy

Sarah Weiss · 2023
ClinicalTrials.gov · Datasets · License: Public Domain · 2023
Open Source ↗
immune-checkpoint-inhibitorsmelanomank-cellsskin-cancert-cellstumor-microenvironment
advanced melanoma, melanoma, metastatic melanoma, skin cancer, immune checkpoint inhibitors, propranolol, naltrexone, beta-adrenergic blocker, opioid receptor antagonist, tumor microenvironment, nk cells, t-cells
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 892860
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.